Integrative Medicine Oncology Department

Home>Medical Features>Department Introduction>Integrated Traditional Chinese and Western Medicine Oncology Department Integrated Traditional Chinese and Western Medicine Oncology Department Large, Medium and Small] The Department of Integrated Traditional Chinese and Western Medicine Oncology of China-Japan Friendship Hospital is a national key clinical specialty, a key specialty/key discipline of the State Administration of Traditional Chinese Medicine, a national cancer clinical pharmacology base, and a clinical teaching base for oncology nurses of the Chinese Nursing Association. The director of the department is Jia Liqun, the deputy directors of the department are Li Yuan and Lou Yanni, and the head nurse is Qi Hongying. The department currently has 4 doctoral supervisors and 7 master's degree supervisors; 7 chief physicians, 2 deputy chief physicians, 5 attending physicians, 4 resident physicians, 7 supervisory nurses, and 11 nurse practitioners. The general department currently has 72 inpatient beds, which are divided into two wards: the main ward and the western ward. Relying on the large-scale comprehensive diagnosis and treatment platform of China-Japan Hospital, the department features traditional Chinese medicine and combines modern advanced tumor prevention and treatment technologies to carry out tumor chemotherapy, radiotherapy, targeted and immunotherapy, tumor cryo-interventional therapy, etc., and has achieved remarkable results in improving patients' quality of life and prolonging survival.The department was established in 1984. The first department director, Professor Zhang Daizhao, is one of the founders of the national integrated traditional Chinese and Western medicine oncology discipline. He has laid down basic treatment principles and methods for the prevention and treatment of adverse reactions of radiotherapy and chemotherapy with traditional Chinese medicine. The Fuzheng Jiedu Granules, represented by prescriptions, have certain effects in improving the quality of life of tumors. He has also made important contributions to the research on the application of traditional Chinese medicine in the prevention and treatment of esophageal cancer in areas with high incidence of tumors in the last century. The second department director, Professor Li Peiwen, is a famous Chinese medicine teacher in the capital and an academic inheritance instructor for veteran Chinese medicine experts across the country. He has done a lot of work in the palliative treatment of tumors with traditional Chinese and Western medicine, and has developed a variety of in-hospital preparations to improve the efficacy of tumor complications in patients with intermediate and advanced stages.The current director of the department, Professor Jia Liqun, is the first famous Chinese medicine doctor in the capital. He serves as the chairman of the Prevention and Health Care Branch of Integrated Traditional Chinese and Western Medicine of the Chinese Society of Preventive Medicine, a director of the Chinese Society of Traditional Chinese Medicine and the honorary deputy chairman of the Oncology Branch, and a member of the National Pharmacopoeia Commission. He enjoys special government subsidies from the State Council and is committed to inheriting and innovating. Under the guidance of the spirit, he established a technical system for the external treatment of tumor complications with traditional Chinese medicine, wrote the first monograph on external tumor treatment, and as the leader of the National Traditional Chinese Medicine Oncology Collaborative Group, he carried out research and promotion of traditional Chinese medicine tumor screening and prevention and treatment technology in areas with high incidence of esophageal cancer, and created a national medical consortium of integrated traditional Chinese and Western medicine oncology specialists. Diagnosis and treatment features of the department: After more than 30 years of clinical practice and innovation, the department has esophageal cancer, lung cancer, breast cancer, colorectal cancer, and neuroendocrine tumors as its five dominant diseases, and is characterized by external treatment with traditional Chinese medicine and argon-helium cryotherapy technology. Esophageal Cancer: As the leading unit of the National Traditional Chinese Medicine Esophageal Cancer Collaboration Group, it undertakes the National Administration of Traditional Chinese Medicine’s esophageal cancer collaborative research project of traditional Chinese and Western medicine, formulated an expert consensus on the diagnosis and treatment of esophageal cancer using integrated traditional Chinese and Western medicine, and established a screening and prevention system for esophageal precancerous lesions based on tongue diagnosis. Developing experience-related prescriptions for esophageal cancer: Anticancer B Pills, Tongyou Decoction Modified Recipes, Ulcer Shengsheng Recipes, etc. Attending physicians: Jia Liqun, Lou Yanni.Lung cancer: Featuring traditional Chinese medicine combined with targeted and immunotherapy, it has obvious advantages in prolonging the survival time of intermediate and advanced lung cancer, and can reduce lung cancer-related adverse reactions. It has won the National Science and Technology Progress Award (Cooperation) and the Science and Technology Award of the China Association of Traditional Chinese Medicine. Research and development of lung cancer-related prescriptions and in-hospital preparations: Pingfei oral liquid, Shipi Xiaoshui ointment, Zizao Yangrong decoction, etc. Attending physicians: Cui Huijuan, Li Liya. Breast Cancer: It features integrated traditional Chinese and Western medicine in the treatment of triple-negative breast cancer. Through traditional Chinese medicine treatment, it reduces the risk of recurrence of mid- and late-stage breast cancer and alleviates the adverse reactions of breast cancer treatment drugs. It is the chairman unit of the Breast Cancer Prevention and Treatment Association Integrated Traditional Chinese and Western Medicine Prevention and Treatment Committee, and has established a "Pink Ribbon Club" for the rehabilitation of breast cancer patients. Research and development of breast cancer-related prescriptions and in-hospital preparations: Luci Sanjie prescription and Tongkuaixiao oral liquid. Attending physician: Wan Donggui. Neuroendocrine tumors: A multidisciplinary diagnosis and treatment team featuring traditional Chinese medicine has been established, which has reached the domestic leading level in the treatment of gastrointestinal and pancreatic neuroendocrine tumors, and participated in the formulation of CSCO neuroendocrine tumor diagnosis and treatment guidelines. Developing experience-related prescriptions for neuroendocrine tumors: Shumu Jianpi Recipe. Attending physician: Tan Huangying.Colorectal cancer: Features traditional Chinese medicine combined with chemotherapy and targeted therapy to improve the quality of life of colorectal cancer patients. On the basis of TCM syndrome differentiation and treatment, combined with modern medical diagnosis and treatment guidelines, an individualized treatment plan was formed to solve complications such as diarrhea and hand-foot syndrome caused by treatment for colorectal cancer patients. Colorectal cancer-related experience prescriptions and hospital preparations were developed: Tiaopi Anchang Prescription, Flavored Ginger Xiexin Decoction, Tongluo Powder, etc. Attending physicians: Cheng Zhiqiang, Li Yuan, Li Xue. Indications of external treatment techniques of traditional Chinese medicine: cancer pain, cancerous ascites, spontaneous sweating, abdominal distension, nausea and vomiting after chemotherapy, non-healing postoperative wounds, lymphedema, radiation proctitis, radiation esophagitis, radiation dermatitis, oral ulcers after radiotherapy and chemotherapy, hand-foot syndrome, hand-foot skin reaction, etc. Indications of argon-helium cryointerventional therapy: local treatment of lung cancer, liver cancer and other malignant tumors, combined with the overall treatment of traditional Chinese medicine, improves the remission rate of tumors. The department’s scientific research and teaching achievements: presided over and undertaken more than 30 national, provincial and ministerial level projects, including 10 National Natural Science Foundation projects under research, won 8 National Science and Technology Progress Awards (cooperation) and provincial and ministerial science and technology awards, obtained 5 national invention patents, edited more than 20 oncology monographs, and more than 30 popular science books.Responsible for the teaching of integrated traditional Chinese and Western medicine oncology at Beijing University of Chinese Medicine, editor-in-chief of 2 textbooks, and has been rated as an advanced teaching department at the hospital level many times. Every year, it trains more than 20 doctoral and master's students, more than 10 training doctors, and more than 40 residents and clinical pharmacists. It has created a talent training model for integrated traditional Chinese and Western medicine and built a teaching platform for integrated traditional Chinese and Western medicine. Location in the hospital: The outpatient department of the department is located on the 2nd floor of Building M, and the inpatient ward of the department is located on the east side of the 5th floor of Building A. The West District of China-Japan Hospital is located at No. 2, Shuangquanbao A, Chaoyang District, Beijing. The West District outpatient department of the department is located on the 2nd floor, and the inpatient ward is located on the 6th floor. Department phone number: Headquarters: outpatient clinic 010-84206495, ward 010-84205733, nurse station 010-84205732; West District: ward 010-53236565. Share to:X